Imigran

Imigran is owned by GSK plc, headquartered in the United Kingdom. No. The ultimate owner of Imigran, GSK plc, is headquartered in the United Kingdom, not in the United States.

GSK is a global biopharma company that prioritizes innovation in vaccines and specialty medicines to prevent and treat disease.

GlaxoSmithKline AB